FDA COVID-19 Booster Shot Update (10/20/201)

Updated: Oct 22, 2021

On October 20, 2021, the FDA expanded the Emergency Use Authorization for the COVID-19 Booster shots. On October 21, 2021, the CDC director signed the recommendations to include the following:

  • A single booster dose of the Moderna COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals:

  • 65 years of age and older

  • 18 through 64 years of age at high risk of severe COVID-19

  • 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2

  • A single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.

Additionally, the FDA is now allowing for the “mix and match” approach for the booster. Individuals who are eligible for the booster, which include those populations listed above if the primary series was Moderna or Pfizer, or anyone 18 years old and up if they had the Jansen (Johnson and Johnson) vaccine, can now have a booster dose of any available COVID-19 vaccine even if it is different from their primary vaccination series.

If you have specific questions regarding this, please reach out to your provider via the Patient Portal, or call the office at 978-774-2555.